§ 5404. Improving access to cancer clinical trials
Purdon's Pennsylvania Statutes and Consolidated StatutesTitle 35 Pa.C.S.A. Health and SafetyEffective: April 24, 2019
Effective: April 24, 2019
35 Pa.C.S.A. § 5404
§ 5404. Improving access to cancer clinical trials
(2) Reimbursement for travel and ancillary expenses shall not be considered coercive or exerting undue influence to participate in a trial; instead, reimbursement shall be considered a means to create parity in clinical trial access and remove a barrier to participation for financially burdened patient-subjects.
(2) A third-party reimbursement entity shall register with a department-approved Pennsylvania college or university with a school of public health. Registration must occur within 30 days of the date the third-party reimbursement entity first reimbursed a patient-subject, or the patient-subject's family, friends or chaperones, for travel or ancillary expenses related to a cancer clinical trial conducted within this Commonwealth.
(1) Reimbursement programs that cover ancillary medical and travel expenses must be reviewed and approved by the IRB or IEC in conjunction with their review of the proposed clinical trial. The IRB or IEC must consider whether the reimbursed patient-subjects are recruited fairly, informed adequately and paid appropriately.
Credits
2018, Oct. 24, P.L. 650, No. 93, § 2, effective in six months [April 24, 2019].
35 Pa.C.S.A. § 5404, PA ST 35 Pa.C.S.A. § 5404
Current through Act 13 of the 2024 Regular Session. Some statute sections may be more current, see credits for details.
End of Document |